Consumer Marketing briefs

Share this article:
The American Cancer Society Cancer Action Network launched a print and online campaign in key congressional districts urging lawmakers to renew funding for the CDC's National Breast and Cervical Cancer Early Detection Program. The print ad depicts a blindfolded woman along with the words “We can't fight cancer if we can't see it.”

Takeda seized on FDA uncertainty over GSK's Avandia with a campaign for its own oral diabetes drug, Actos, in July. A print ad, by AbelsonTaylor, appeared in 154 publications and national mags, advising readers: “Actos has been shown to lower blood sugar without increasing your risk of having a heart attack or stroke.”

The Amgen Foundation is partnering with Ashoka's Changemakers, a social networking group, on an online competition aimed at patient empowerment. The contest invites entries on the theme of “Patients/choices/empowerment” that offer “innovative solutions that elevate patients' voices to improve health outcomes.” Prizes include three $10,000 cash prizes to further proposed projects, along with “further opportunities offered by The Amgen Foundation.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?